Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Read our pernicious anemia diet page for more advice
Except for repeated measure (RM) tests, measurements were taken from distinct samples
The SURPASS trial series (SURPASS 1-5) and SURMOUNT series provide granular data across diverse populations including patients with cardiovascular disease, chronic kidney disease, and diabetes making Tirzepatide the more data-rich compound for translational research applications
The starting dose of lixisenatide is 10 ug subcutaneously once daily within one hour before the first meal of the day for 14 days and then increase the dose to the maintenance dose of 20 ug once daily
US$ 20.69
US$ 24.52
US$ 22.25
